RARE ASSOCIATION OF NEUROFIBROMATOSIS TYPE 1 WITH PRIMARY HYPERPARATHYROIDISM: A CASE REPORT
DOI:
https://doi.org/10.15605/jafes.037.S2.17Keywords:
neurofibromatosis, hyperparathyroidismAbstract
INTRODUCTION
Neurofibromatosis Type 1 is an autosomal dominant genetic disorder characterized by central nervous system involvement, cutaneous manifestations and increased risk of developing endocrine-related tumors. Meanwhile, Primary Hyperparathyroidism is most commonly caused by parathyroid adenoma resulting in abnormal calcium homeostasis. There are case reports identifying an association between neurofibromatosis and primary hyperparathyroidism as a variant of multiple endocrine neoplasia (MEN) syndrome, however, their association is not fully understood.
CASE
This is the case of a 50-year-old male patient who is known to have neurofibromatosis type 1 with cutaneous manifestations (cafe au lait spots, neurofibromas, Lisch nodules) and pleural neurofibroma. He initially presented with persistent left lumbar pain and a kidney ultrasound demonstrated evidence of left nephrolithiasis. Laboratory tests revealed high serum calcium of 2.7 mmol/L to 3.1 mmol/L, a low phosphate level of 0.49 mmol/L and a markedly raised serum parathyroid hormone level of 1038 pg/ml. Vitamin D level was normal at 72.26 nmol/L and a calcium-to-creatinine-ratio of 0.019. Further workup with Sestamibi parathyroid scan revealed evidence of parathyroid adenoma inferior to the left thyroid gland. Contrast-enhanced computed tomography of the neck showed a heterogeneously-enhancing lesion in the same location corresponding with the Sestamibi scan finding. There was no clinical evidence of pheochromocytoma and the 24-hour urine metanephrines test was normal. With the imminent complication of nephrolithiasis, the patient is awaiting parathyroidectomy.
CONCLUSION
This case demonstrates a rare but proven co-occurrence between neurofibromatosis and primary hyperparathyroidism as evidenced by biochemical tests and radiographic imaging. Screening neurofibromatosis patients for primary hyperparathyroidism during the initial evaluation and follow-up is a potential step for early detection of the condition before it leads to complications.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Melody Tsen Shu Ling, Mohd Idris Bin Mohd Diah, Tee Hwee Ching

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.





